Vecura

Vecura is an AI-enabled life science discovery company/platform focused on integrating drug discovery workflows into a single operating system for research teams. The platform is designed to connect target identification, virtual screening, compound optimization, and translational planning without requiring users to build their own machine-learning infrastructure. Public materials indicate that Vecura is associated with Nanyang Biologics and is being positioned as a proprietary platform to accelerate discovery from natural-source compound libraries. Its stated use cases span oncology, neuroscience, metabolic health, and related therapeutic discovery efforts. The company appears to be focused on enabling earlier-stage R&D and partnering/licensing opportunities rather than marketing approved therapeutics.